Wnt signaling in B-cell neoplasia

被引:131
作者
Qiang, YW [1 ]
Endo, Y [1 ]
Rubin, JS [1 ]
Rudikoff, S [1 ]
机构
[1] NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA
关键词
Wnt; beta-catenin; myeloma; morphology; Rho;
D O I
10.1038/sj.onc.1206239
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Wnts comprise a family of secreted proteins that interact with receptors consisting of a Frizzled (Fz) family member alone or complexed with LDL receptor-related proteins (LRP5/6). Wnt signaling plays a crucial role in both development and differentiation, and activation of a 'canonical' Writ pathway resulting in P-catenin stabilization is associated with several types of human cancers. To date, little is known about potential Wnt signaling in mature lymphocytes or lymphoid neoplasia. Herein, we have analysed Wnt signaling in mature B cells (lymphomas) and plasma cells (multiple myeloma). Both Fz and LRP5/6 mRNAs were expressed in myeloma lines, but LRP5/6 were not observed in lymphomas. In myelomas, a canonical Wnt signaling pathway was activated following treatment with Wnt-3a as assessed by accumulation of beta-catenin, but beta-catenin levels actually decreased in lymphoma cells. Wnt-3a treatment further led to striking morphological changes in myeloma cells accompanied by rearrangement of the actin cytoskeleton. Morphological changes were associated with a second Wnt pathway dependent on Rho activation. These results suggest that Writ responsiveness is a stage-specific phenomenon in B-cell development and that the morphological changes associated with Wnt signaling may play a role in the motility and metastatic potential of myeloma cells.
引用
收藏
页码:1536 / 1545
页数:10
相关论文
共 39 条
[1]   MECHANISMS OF BONE-LESIONS IN MULTIPLE-MYELOMA [J].
BATAILLE, R ;
CHAPPARD, D ;
KLEIN, B .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (02) :285-295
[2]   INTERLEUKIN-3 AND INTERLEUKIN-6 SYNERGISTICALLY PROMOTE THE PROLIFERATION AND DIFFERENTIATION OF MALIGNANT PLASMA-CELL PRECURSORS IN MULTIPLE-MYELOMA [J].
BERGUI, L ;
SCHENA, M ;
GAIDANO, G ;
RIVA, M ;
CALIGARISCAPPIO, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (02) :613-618
[3]   WNT signaling modulates the diversification of hematopoietic cells [J].
Brandon, C ;
Eisenberg, LM ;
Eisenberg, CA .
BLOOD, 2000, 96 (13) :4132-4141
[4]   Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway [J].
Ferlin, M ;
Noraz, N ;
Hertogh, C ;
Brochier, J ;
Taylor, N ;
Klein, B .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (02) :626-634
[5]  
Ge NL, 2000, BLOOD, V96, P2856
[6]   LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development [J].
Gong, YQ ;
Slee, RB ;
Fukai, N ;
Rawadi, G ;
Roman-Roman, S ;
Reginato, AM ;
Wang, HW ;
Cundy, T ;
Glorieux, FH ;
Lev, D ;
Zacharin, M ;
Oexle, K ;
Marcelino, J ;
Suwairi, W ;
Heeger, S ;
Sabatakos, G ;
Apte, S ;
Adkins, WN ;
Allgrove, J ;
Arslan-Kirchner, M ;
Batch, JA ;
Beighton, P ;
Black, GCM ;
Boles, RG ;
Boon, LM ;
Borrone, C ;
Brunner, HG ;
Carle, GF ;
Dallapiccola, B ;
De Paepe, A ;
Floege, B ;
Halfhide, ML ;
Hall, B ;
Hennekam, RC ;
Hirose, T ;
Jans, A ;
Jüppner, H ;
Kim, CA ;
Keppler-Noreuil, K ;
Kohlschuetter, A ;
LaCombe, D ;
Lambert, M ;
Lemyre, E ;
Letteboer, T ;
Peltonen, L ;
Ramesar, RS ;
Romanengo, M ;
Somer, H ;
Steichen-Gersdorf, E ;
Steinmann, B .
CELL, 2001, 107 (04) :513-523
[7]   Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel formin homology protein Daam1 [J].
Habas, R ;
Kato, Y ;
He, X .
CELL, 2001, 107 (07) :843-854
[8]   INTERLEUKIN-6 IS ESSENTIAL FOR IN-VIVO DEVELOPMENT OF B-LINEAGE NEOPLASMS [J].
HILBERT, DM ;
KOPF, M ;
MOCK, BA ;
KOHLER, G ;
RUDIKOFF, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) :243-248
[9]   The β-catenin-TCF-I pathway ensures CD4+CD8+ thymocyte survival [J].
Ioannidis, V ;
Beermann, F ;
Clevers, H ;
Held, W .
NATURE IMMUNOLOGY, 2001, 2 (08) :691-697
[10]  
Ishizaki T, 2000, MOL PHARMACOL, V57, P976